Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing WHO grade for brain astrocytomas

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 6, 2014, Pages 1569-1574

  Wang, Xiao Chun ^a   Zhang, Hui ^a   Tan, Yan ^a   Qin, Jiang Bo ^a   Wu, Xiao Feng ^a   Wang, Le ^a   Zhang, Lei ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

astrocytoma; diagnosis; differential; magnetic resonance imaging; perfusion; susceptibility

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BLOOD FLOW; CANCER GRADING; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUSCEPTIBILITY WEIGHTED IMAGING; WORLD HEALTH ORGANIZATION; BRAIN; BRAIN NEOPLASMS; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; REPRODUCIBILITY OF RESULTS; ROC CURVE; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84900002039     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24312     Document Type: Article

References (12)

1. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004; 25: 746-755.
2. Law M, Young R, Babb J, et al. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007; 28: 761-766.
3. Lupo JM, Cha S, Chang SM, et al. Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. AJNR Am J Neuroradiol 2007; 28: 1455-1461.
4. Hilario A, Ramos A, Perez-Nunez A, et al the added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. AJNR Am J Neuroradiol 2012, 33: 701-707.
5. Park MJ, Kim HS, Jahng GH, et al. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol 2009; 30: 1402-1408.
6. Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009; 30: 232-252.
7. Kim HS, Jahng GH, Ryu CW, et al. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009; 30: 1574-1579.
8. Park SM, Kim HS, Jahng GH, et al. Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T. Br J Radiol 2010; 83: 466-475.
9. Caseiras GB, Chheang S, Babb J, et al. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. Eur J Radiol 2010; 73: 215-220.
10. Sawlani RN, Raizer J, Horowitz SW, et al. Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging - pilot study. Radiology 2010; 255: 622-628.
11. Pinker K, Noebauer-Huhmann IM, Stavrou I, et al. High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol 2007; 28: 1280-1286.
12. Hori M, Mori H, Aoki S, et al. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas. Magn Reson Imaging 2010; 28: 594-598.